We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| McKesson Corporation | NYSE:MCK | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 11.02 | 2.03% | 554.625 | 554.625 | 543.89 | 543.89 | 367,421 | 18:46:27 |
From May 2019 to May 2024
By Stephen Nakrosis
McKesson Corp. (MCK) said Thursday it will continue to serve as the prime pharmaceutical provider for the U.S. Department of Veterans Affairs.
The new deal, which takes effect in August of next-year, calls for a two-year contract and options for up to three two-year extensions.
McKesson will continue to supply pharmaceuticals to the department's more than 750 locations, it said, adding the Department of Veterans Affairs runs the nation's largest integrated healthcare system.
McKesson said it has been serving as the department's prime pharmaceutical provider since 2004.
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
December 12, 2019 11:28 ET (16:28 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year McKesson Chart |
1 Month McKesson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
